5090 J. Am. Chem. Soc., Vol. 119, No. 22, 1997
McGall et al.
MHz): δ 7.50 (s, 1H, HAr-MeNPOC), 7.09 (s, 1H, HAr-MeNPOC), 6.27
triester was detritylated by dissolving it in 2.5 mL of DCM/MeOH
(6:1) containing 6% trichloroacetic acid. After 5 min, 10 mL of EtOAc
was added, and the solution was washed with saturated aqueous
NaHCO3 and brine (5 mL each). The organic phase was dried (Na2SO4)
and evaporated, and the crude product purified by flash chromatography
(DCM/MeOH, 9:1) to obtain 12 mg (79%) of 12. 1H NMR (CDCl3,
400 MHz): δ 9.72 (br s, 1H, HN2), 8.02 (2s, 1H, HC8), 7.32 (t, 2H,
HAr-pac), 7.05 (t, 1H, HAr-pac), 6.99 (d, 2H, HAr-pac), 6.39 (t, 1H, HC1′),
5.31 (br s, 1H, HC3′), 4.62 (s, 2H, Hpac), 4.38 (br s, 1H, HC4′), 4.34-
(quartet, J ) 6.5 Hz, 1H, HArCH-MeNPOC), 6.12 (br s, 2H, HOCH O-MeNPOC),
2
4.80 (br s, 1H, HOH1), 4.31-4.19 (m, 2H, HC17), 3.73-3.59 (m, 22H,
H
C1-16), 1.64 (d, J ) 8Hz, 3H, HCH -MeNPOC). ESI-MS: 520 (M +
3
H+), 537 (M + H2O+), 542 (M + Na+).
MeNPOC-HEG-OH (80 g, 154 mmol) was coevaporated three times
with 300 mL of dry toluene, and combined with 2-cyanoethyl N,N,N′,N′-
tetraisopropylphosphorodiamidite (55.7 g, 185 mmol) and diisopropyl-
ammonium tetetrazolide (6.4 g, 77 mmol) in 600 mL of dry DCM under
argon at room temperature. The solution was stirred overnight and
then transferred to a separatory funnel and washed twice with saturated
aqueous NaHCO3 and once with saturated brine (400 mL each). After
drying with Na2SO4, the organic phase was evaporated and the crude
product was purified by flash chromatography (0-50% EtOAc in DCM/
0.5% triethylamine) to give 87 g (78.5%) of 9 (purity 98% pure by
HPLC; 100% by 31P NMR). 1H NMR (CDCl3, 400 MHz): δ 7.50 (s,
1H, HAr-MeNPOC), 7.09 (s, 1H, HAr-MeNPOC), 6.27 (quartet, J ) 6.5 Hz,
4.27 (m, 2H, HCE), 3.98-3.93 (m, 1H, HC5′a), 3.84 (d, 3H, HCH O-P),
3
3.84-3.76 (m, 1H, HC5′b), 3.03-2.94 (br m, 1H, HC2′a), 2.81 (br m,
1H, HCE), 2.72-2.64 (m, 1H, HC2′b). 31P NMR (CDCl3, 162 MHz): δ
+0.93. Anal. Calcd for C22H25N6O9P: C, 48.18; H, 4.59; N, 15.32;
P, 5.65. Found: C, 48.65; H, 4.58; N, 14.73; P, 5.40. FAB-MS(HR):
m/z calcd for C22H26N6O9P (M + H+) 549.14989, obsd 549.14916.
1,3-bis-[(R,S)-((1-(3,4-(Methylenedioxy)-6-nitrophenyl)ethoxy)-
carbonyl)oxy]propane (13). A solution of 2.5 g (9.15 mmol) in 3
mL of dry DCM was added slowly with stirring to a cold solution of
1,3-propanediol in 5 mL of dry pyridine under argon. After stirring
overnight at room temperature, 50 mL of EtOAc was added, the solution
was filtered to remove pyr‚HCl, and the solvents were evaporated. The
crude products were purified by flash chromatography (hexane/EtOAc,
3:2) to obtain 1.2 g of 13 (mixture of diastereomers). UV-vis
(dioxane): 245 nm (λmax, 2.5 × 104), 294 nm (sh, 6.5 × 103), 344 nm
(λmax, 1.03 × 104). 1H NMR (DMSO-d6, 400 MHz): δ 7.49 (2s, 2H),
7.06 (s, 2H), 6.27-6.21 (m, 2H), 6.12 (s, 4H), 4.22-4.11 (m, 4H),
1.99 (quintet, 2H), 1.63 (d, 6H). EI-MS: 573 (M+•). Anal. Calcd
for C13H15NO8: C, 49.84; H, 4.83; N, 4.87. Found: C, 49.55; H, 4.82;
N, 4.55.
1H, HArCH-MeNPOC), 6.12 (br s, 2H, HOCH O-MeNPOC), 4.30-4.18 (m, 2H,
2
H
C17), 3.90-3.80 (m, 3H, HC1, CE-a), 3.76-3.58 (m, 23H, HC2-16,CH-iPr,
CE-a), 2.65 (t, J ) 8 Hz, HCE-b), 1.65 (d, J ) 8 Hz, 3H, HCH -MeNPOC),
3
1.21-1.16 (m, 12H, HCH -iPr). 31P NMR (CDCl3, 162 MHz): δ +148.7.
3
ESI-MS: 720 (M + H+), 742 (M + Na+), 821 (M + Et3NH+). Anal.
Calcd for C31H51N3O14P: C, 51.66; H, 7.13; N, 5.83; P, 4.30. Found:
C, 51.70; H, 6.82; N, 5.73; P, 4.04.
5′-O-(R,S)-(1-(3,4-(Methylenedioxy)-6-nitrophenyl)]ethoxy)carbo-
nyl]-N2-(phenoxyacetyl)-2′-deoxyguanosine 3′-O-(2-Cyanoethyl)-
methyl Phosphate (10). Anhydrous methanol (1.73 mL, 39 mmol)
was added to a solution of MeNPOC-(pac)dG-CEP (7c, 3.26 g, 3.9
mmol) in 10 mL of dry CH3CN under argon, and a solution of tetrazole
(0.45 M in CH3CN, 10 mL, 4.5 mmol) was added slowly with stirring.
After 15 min, 50 mL of EtOAc was added, and the solution was washed
with saturated aqueous NaHCO3 and brine (50 mL each). The organic
phase was dried (Na2SO4) and evaporated, and the crude product
purified by flash chromatography (DCM/MeOH, 97:3) to obtain 1.7 g
(57%) of 5′-MeNPOC-N2-(phenoxyacetyl)-2′-deoxyguanosine 3′-O-(2-
cyanoethyl)methyl phosphite (mixture of diastereomers). 1H NMR
(CDCl3, 400 MHz): δ 9.50 (br s, 1H, HN2), 7.86, 7.80 (2s, 1H, HC8),
7.40, 7.36 (2s, 1H, HAr-MeNPOC), 7.34-7.28 (m, 2H, HAr-PAC), 7.05 (t,
1H, HAr-PAC), 7.00-6.94 (m, 2H, HAr-PAC), 6.99, 6.86 (2s, 1H,
3-[(R,S)-((1-(3,4-(Methylenedioxy)-6-nitrophenyl)ethoxy)carbo-
nyl)oxy]propan-1-ol (14) was prepared by the method described for
9. UV-vis (dioxane): 244 nm (λmax, 1.23 × 104), 294 nm (sh, 3.4 ×
103), 345 nm (λmax, 5.2 × 103). 1H NMR (DMSO-d6, 400 MHz): δ
7.50 (s, 1H), 7.07 (s, 2H), 6.26 (quartet, 1H), 6.12 (s, 2H), 4.31-4.19
(octet, 2H), 3.70 (br m, 2H), 1.89 (quintet, 2H), 1.64 (d, 3H). ESI-
MS: 314 (M + H+), 336 (M + Na+). Anal. Calcd for C23H22N2O14:
C, 50.19; H, 4.03; N, 5.09. Found: C, 50.18; H, 3.95; N, 4.99.
Methyl 3,4-(Methylenedioxy)-6-nitrosophenyl Ketone (11).
A
solution of 1.2 g R-methyl-3,4-(methylenedioxy)-6-nitrobenzyl alcohol
(3) in 40 mL of acetonitrile was circulated through a 75 × 75 mm (1
mm path length) quartz flowcell under continuous exposure to near-
UV irradiation (10 mW/cm2 at 365 nm) from a 500 W collimated
mercury arc light source (model 87330, Oriel Instruments, Stratford,
CT) for 4 h. The partially photolyzed mixture was evaporated to
dryness and purified by flash chromatography (DCM). The product
eluted as a green band (TLC, Rf ) 0.35/DCM), which was reduced in
Vacuo to induce crystallization of the product as green-yellow crystals
(250 mg), purity 97% by HPLC (5-80% CH3CN over 25 min). UV-
vis (dioxane): 263 nm (λmax, 1.4 × 104), 328 nm (sh, 4.3 × 103), 382
nm (λmax, 9.5 × 103). 1H NMR (DMSO-d6, 400 MHz): δ 7.49 (s,
1H), 6.35 (s, 2H), 6.82 (s, 1H), 2.79 (s, 3H). 13C NMR (DMSO-d6,
100 MHz): δ 210.8, 161.0, 154.7, 150.4, 143.7, 106.9, 104.2, 89.0,
33.2. EI-MS: 193 (M+•). Anal. Calcd for C9H7NO4: C, 55.96; H,
3.65; N, 7.25. Found: C, 55.73; H, 3.75; N, 7.07.
H
Ar-MeNPOC), 6.32-6.26 (m, 1H, HC1′), 6.24-5.98 (m, 3H, HMeNPOC),
5.10-4.95 (br d, 1H, HC3′), 4.72-4.62 (m, 2H, Hpac), 4.43-4.32 (m,
3H, HC5′,4′), 4.08-4.02 (m, 2H, HCE), 3.60 (d, 3H, HCH O), 2.93-2.82
3
(m, 1H, H2′a), 2.70 (t, 2H, HCE), 2.65-2.47 (m, 1H, HC2′b), 1.62-1.56
(m, 3H, HCH -MeNPOC). 31P NMR (CDCl3, 162 MHz): δ +140.6.
3
The nucleoside 3′-phosphite triester (1.5g, 1.95 mmol) was combined
with 5 mL of 10% aqueous H2O2 in 5 mL of THF. After 5 min, 25
mL of EtOAc was added, and the solution was washed with saturated
aqueous NaHCO3 and brine (25 mL each). The organic phase was
dried (Na2SO4) and evaporated, and the crude product purified by flash
chromatography (DCM/MeOH, 97:3) to obtain 1.2 g (77%) of 10
(mixture of diastereomers). 1H NMR (CDCl3, 400 MHz): δ 9.77, 9.51
(2d, 1H, HN2), 7.85, 7.79 (2s, 1H, HC8), 7.40, 7.36 (2s, 1H, HAr-MeNPOC),
7.35-7.29 (m, 2H, HAr-pac), 7.06 (t, 1H, HAr-pac), 7.02-6.96 (m, 2H,
H
Ar-pac), 6.98, 6.85 (2s, 1H, HAr-MeNPOC), 6.32-6.26 (m, 1H, HC1′),
6.24-5.98 (m, 3H, HMeNPOC), 5.33-5.16 (br d, 1H, HC3′), 4.74-4.58
(m, 2H, Hpac), 4.46-4.26 (mm, 5H, HC5′,4′, HCE), 3.86 (d, 3H, HCH O-P),
3
3.07-2.93 (m, 1H, HC2′a), 2.82 (t, 2H, HCE), 2.80-2.62 (m, 1H, HC2′b),
1.62-1.56 (m, 3H, HMe-MeNPOC). 31P NMR (CDCl3, 162 MHz): δ
+0.15. Anal. Calcd for C32H33N7O15P: C, 48.92; H, 4.11; N, 12.48;
P, 3.94. Found: C, 48.54; H, 4.00; N, 12.06; P, 3.89. FAB-MS(HR):
m/z calcd for C32H33N7O15P (M + H+) 786.17723, obsd 786.17741.
N2-(Phenoxyacetyl)-2′-deoxyguanosine 3′-O-(2-Cyanoethyl)methyl
Phosphate (12). The same method described above for the preparation
of 10 was used to prepare 5′-DMT-N2-pac-2′-deoxyguanosine 3′-O-
(2-cyanoethyl)methyl phosphate from the commercially available
phosphoramidite. 1H NMR (CDCl3, 400 MHz): δ 9.50 (s, 1H, HN2),
7.85 (2s, 1H, H8), 7.42-6.78 (m, 18H, HAr-DMT,pac), 6.30 (t, 1H, H1′),
5.34-5.22 (br m, 1H, H3′), 4.69 (s, 2H, Hpac), 4.29-4.25 (m, 1H, H4′),
4.25-4.15 (m, 2H, HCE), 3.82 (d, 3H, HMeO-P), 3.77 (s, 6H, HMeO-DMT),
3.42-3.32 (m, 2H, H5′), 2.88-2.65 (m, 4H, H2′, HCE). 31P NMR
(CDCl3, 162 MHz): δ +0.90.
Acknowledgment. The authors thank the NIH for financial
support. We also thank the following individuals at Affymetrix
for their generous assistance: Jim Winkler, David Stern, JoAnn
Iwasa, Martin Goldberg, Peter Feikowsky, Rita Wespi, and
Richard Rava.
Supporting Information Available: Synthetic procedures
and analytical data (NMR, MS, elemental) are available for N2-
(4,4′-dimethoxytrityl)-2′-deoxyguanosine, O6-(N,N-diphenylcar-
bamoyl)-N2-(phenoxyacetyl)-2′-deoxyguanosine, all 5′-MeNPOC-
2′-deoxynucleosides (6a-k), and phosphoramidites (7a-k) (12
pages). See any current masthead page for ordering and Internet
access instructions.
A portion (180 mg, 220 µmol) of the DMT nucleoside phosphate
JA964427A